Integrating preventive cardiology in primary care

Abstract

Background: Chronic metabolic and cardiovascular multi-comorbidities are increasing, with cardiovascular disease being the main cause of morbidity and mortality in type 2 diabetes patients. Traditional healthcare systems often lack a "main" specialist coordinating treatment, leading to fragmented care and higher costs. Advances in cardiometabolic pharmacology have blurred lines between specialties, emphasizing the need for a distinct cardiometabolic specialty. This interdisciplinary approach aims to optimize treatment, improve outcomes, and reduce medical expenditure. Aim of Work: The significant prevalence of cardiovascular disease and the concurrent obesity epidemic is exerting an exceptional pressure on the healthcare system. Under the present fragmented care paradigm, patients with cardiometabolic illness get only partial care from several experts, resulting in inadequate therapy, increased expenses, and worse results. Methods: A thorough and methodical search was conducted across several databases, including PubMed (including MEDLINE), CINAHL, EMBASE, and the Cochrane database for systematic reviews. Reference lists of included papers were also examined for relevant research. Results: There is an urgent need for a new treatment paradigm that involves establishing a separate specialty focused on cardiometabolic conditions, together with a dedicated outpatient clinic that provides complete care for these conditions.